Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Gavin Newsom

19-state coalition sues HHS over restructuring, mass firings

The states argue the Department of Health and Human Services is failing to perform basic functions, in violation of the Constitution, as the agency and its programs are authorized by Congress. 

U.S. FDA Sign

FDA reverses course on some layoffs, rehires FOIA staff

According to a media report, workers managing records on medical device and tobacco regulations are returning to work after the agency missed court-ordered deadlines for Freedom of Information Act responses. 

healthcare surprise billing statement payment

CPT code changes relevant to radiology for 2026

“The ACR encourages its members to review them and consider how the anticipated changes may impact their practices," the college urged recently. 

Medicaid money dollar reimbursement

State lawmaker shelves proposal to expand Medicaid coverage for breast imaging

Florida Senate Bill 1578 was slated for consideration by the full legislature after unanimously passing through three committee votes. 

Thumbnail

White House releases 2026 ‘skinny budget’ calling for $33B in cuts to HHS

The proposal would cut funds to the Centers for Disease Control and Prevention and the National Institutes of Health. However, no reduction was suggested for the Food and Drug Administration. 

Thumbnail

HHS, NIH announce new ‘universal’ vaccine standard for broad-spectrum protection

Currently in development, the “Generation Gold Standard” platform utilizes inert whole viruses to combat more strains of common illnesses, such as COVID and the flu. It’s on track for FDA approval in 2029.

Hologic sees drop in sales and tariff impact on stock price

The vendor's latest earnings report outlines a nearly $35 million decline in mammography sales and projected ramifications from new tariffs. 

Nabil Dib, MD, director clinical and translational research, Dignity Health, and founder of the non-profit International Society for Cardiovascular Translational Research (ISCTR), explains resources ISCTR has to help doctors and start ups navigate regulatory pathways to expedite moving from research to clinical application.

Nonprofit group helps doctors and startups bring new cardiovascular tech to market

Nabil Dib, MD, founder of the International Society for Cardiovascular Translational Research, details resources to help doctors and startups navigate the shift from conducting research to commercializing new products and applications.